March 12, 2025
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has once again been recognized for its innovative prowess. Clarivate has named Philips the top-ranked medical technology company in its Top 100 Global Innovators 2025, marking the 12th consecutive year the company has received this prestigious honor.
“At Philips, we’ve been innovating for over 130 years to improve people’s lives,” stated Roy Jakobs, CEO of Royal Philips. “Innovation is our fundamental strength, driving customer choice and value for our company. Our portfolio of patient- and people-centric innovations in hardware, software, AI, and services enhances healthcare productivity, empowering individuals to manage their health and well-being, ultimately delivering better care to a wider population.”
Philips continues to prioritize research and development, with approximately EUR 1.7 billion – representing over 9% of sales – invested in 2024. The company is increasingly focusing its innovation efforts on the potential of data and AI, both in hospital settings and at home. Philips, a leader in healthcare AI-related patent applications, dedicates about half of its R&D workforce to these fields.
Some of Philips’ notable AI-powered innovations include:
- The Philips CT 5300 integrates advanced hardware, software, and AI to provide high-quality screening, diagnostic, and interventional imaging for a broader range of patients.
- The latest SmartSpeed Precise MRI technology enables scans to be completed up to three times faster, significantly reducing scan times while maintaining exceptional image quality.
- The next-generation AI-enabled cardiovascular ultrasound platform which includes advanced AI tools to advance cardiovascular imaging and increase automation and productivity.
- The new Azurion image-guided therapy system and advanced informatics help advance minimally invasive diagnosis and treatment of stroke and other neurovascular patients.
The Top 100 Global Innovators assessment employs a comprehensive comparative analysis of global invention data to determine the strength of patented ideas, using metrics directly linked to their innovative impact. The complete report is available online [here](N/A – Link Not Provided).
About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is dedicated to enhancing people’s health and well-being through meaningful innovation. The company’s patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in both hospital and home environments. Headquartered in the Netherlands, Philips is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, enterprise informatics, and personal health. In 2024, Philips reported sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in over 100 countries.
For more information, please contact:
Ben Zwirs Philips Global External Relations Tel.: +31 61521 3446 E-mail: media@philips.com
News about Philips can be found at www.philips.com/newscenter.
